MTHFR and colorectal carcinoma: Although results of our study provide the first evidence for 3′-UTR variants in the MTHFR gene as potential biomarkers for use in CRC prevention, a prospective study on a larger cohort of ethnically diverse patients is warranted to validate these findings.